Wednesday, October 7, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· February 17, 2026

Life Science Precision Parts Research Report 2025: A $13.92 Billion Market by 2030 Featuring Key Players - Gemsons, Arc, Precision Resource, Thermo Fisher Scientific, Stryker, Linamar, TS Prototypes

View original at globenewswire.com
Life Science Precision Parts Research Report 2025: A $13.92 Billion Market by 2030 Featuring Key Players - Gemsons, Arc, Precision Resource, Thermo Fisher Scientific, Stryker, Linamar, TS Prototypes Dublin, Feb…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Injection-molded components hold the largest share of over 28% of the global life sciences precision parts market by product type

    80% confidence

  • The Life Science Precision Parts Market was valued at USD 9.50 billion in 2024

    80% confidence

  • The metal segment holds the largest share in material type and is projected to grow at a CAGR of 6.91% during the forecast period

    80% confidence

  • The diagnostic devices segment accounted for the largest global life sciences precision parts market share in 2024

    80% confidence

  • The Life Science Precision Parts Market is projected to reach USD 13.92 billion by 2030

    80% confidence

  • Automation is transforming laboratory and biotech research by replacing labor-intensive tasks with high-throughput, reproducible, and error-free workflows

    80% confidence

  • North America dominates the geography segment in 2024 and is projected to grow steadily at a CAGR of 5.26% from 2024 to 2030

    80% confidence

  • The market is rising at a CAGR of 6.57% from 2024 to 2030

    80% confidence

  • The growth of genomics, personalized medicine, and biopharmaceutical automation is driving strong demand for ultra-precise, biocompatible, and traceable precision parts

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com